Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors.

Chastain DB, Veve MP, Wagner JL.

Antivir Ther. 2019 Sep 30. doi: 10.3851/IMP3335. [Epub ahead of print]

PMID:
31570667
2.

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa.

Pogue JM, Kaye KS, Veve MP, Patel TS, Gerlach AT, Davis SL, Puzniak LA, File TM, Olson S, Dhar S, Bonomo RA, Perez F.

Clin Infect Dis. 2019 Sep 23. pii: ciz816. doi: 10.1093/cid/ciz816. [Epub ahead of print]

PMID:
31545346
3.

Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity.

Chaudhry SB, Veve MP, Wagner JL.

Pharmacy (Basel). 2019 Jul 29;7(3). pii: E103. doi: 10.3390/pharmacy7030103. Review.

4.

Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections.

Veve MP, Stuart M, Davis SL.

Pharmacotherapy. 2019 Aug;39(8):809-815. doi: 10.1002/phar.2301. Epub 2019 Jul 21.

PMID:
31257604
5.

Impact of Reported β-Lactam Allergy on Management of Methicillin-Sensitive Staphylococcus aureus Bloodstream Infections.

Veve MP, January SE, Kenney RM, Zoratti EM, Zervos MJ, Davis SL.

J Pharm Pract. 2019 Apr 16:897190019841737. doi: 10.1177/0897190019841737. [Epub ahead of print]

PMID:
30991876
6.

A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species.

Butts A, Reitler P, Nishimoto AT, DeJarnette C, Estredge LR, Peters TL, Veve MP, Rogers PD, Palmer GE.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00054-19. doi: 10.1128/AAC.00054-19. Print 2019 May.

PMID:
30858206
7.

Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.

Veve MP, Wagner JL.

Pharmacotherapy. 2018 Sep;38(9):935-946. doi: 10.1002/phar.2166. Epub 2018 Aug 20. Review.

PMID:
30019769
8.

Retraction for Flynt et al., "Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam".

Flynt LK, Veve MP, Samuel LP, Tibbetts RJ.

J Clin Microbiol. 2018 May 25;56(6). pii: e00541-18. doi: 10.1128/JCM.00541-18. Print 2018 Jun. No abstract available.

9.

Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction.

Veve MP, Greene JB, Williams AM, Davis SL, Lu N, Shnayder Y, Li DX, Noureldine SI, Richmon JD, Lin LO, Hanasono MM, Pipkorn P, Jackson RS, Hornig JD, Light T, Wax MK, Yiu Y, Bekeny J, Old M, Hernandez D, Patel UA, Ghanem TA.

Otolaryngol Head Neck Surg. 2018 Jul;159(1):59-67. doi: 10.1177/0194599818756299. Epub 2018 Mar 7.

PMID:
29513083
10.

Trowels and Tribulations: Review of Antimicrobial-Impregnated Bone Cements in Prosthetic Joint Surgery.

Athans V, Veve MP, Davis SL.

Pharmacotherapy. 2017 Dec;37(12):1565-1577. doi: 10.1002/phar.2040. Epub 2017 Nov 17. Review.

PMID:
28976593
11.

Considerations for antibiotic prophylaxis in head and neck cancer surgery.

Veve MP, Davis SL, Williams AM, McKinnon JE, Ghanem TA.

Oral Oncol. 2017 Nov;74:181-187. doi: 10.1016/j.oraloncology.2017.09.011. Epub 2017 Sep 22. Review.

PMID:
28943204
12.

Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam.

Flynt LK, Veve MP, Samuel LP, Tibbetts RJ.

J Clin Microbiol. 2016 Dec 28;55(1):334-335. doi: 10.1128/JCM.01920-16. Print 2017 Jan. No abstract available. Retraction in: J Clin Microbiol. 2018 May 25;56(6):.

13.

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.

Veve MP, Wagner JL, Kenney RM, Grunwald JL, Davis SL.

Int J Antimicrob Agents. 2016 Jul;48(1):56-60. doi: 10.1016/j.ijantimicag.2016.04.014. Epub 2016 May 12.

PMID:
27234673

Supplemental Content

Support Center